News About: Pharm. Industry
Short supply of GSK’s Zantac in the domestic marketAn explosion at the Tianjin Port in China has caused difficulties in supplying a part of GSK’s products to the domestic market.
According to the industry concerned on the 7th, ...
|
Excessive competition for ‘blockbuster’ generics to cause rebate controversy
It was already expected. As generics of blockbusters, such as ‘Cialis,’ an erectile dysfunction treatment, were poured out due to patent expiration, rises of concerns about illegal business activities caused by excess...
Real Transaction Drug Price settled temporarily
The drug price reduction argument between the Ministry of Health and Welfare(MOHW) and the pharmaceutical industry, which has boringly continued, was temporarily concluded.
The Korea Pharmaceutical Manufacturers Asso...
Chong Kun Dang’s Duvie found possibility of atherosclerosis improvementAs Chong Kun Dang(President Young-ju Kim) has made a new research result proving that its new diabetes drug, ‘Duvie,’ has possibility of improvement for atherosclerosis, it has ...
|
The great Baraclude generic war with price or marketing power
As the patent of ‘Baraclude(generic name: entecavir, BMS Pharmaceutical Korea), a chronic hepatitis B treatment, will be expired on 9th of October, a great generic war will begin.
Baraclude is a product recording the...
New drug development of Dong-A ST’s Suganon TabThe Ministry of Food and Drug Safety(Minister Seung-hee Kim, MFDS) announced approval of ‘Suganon Tab,’ a Dong-A ST’s new drug developed in the domestic industry, on the 2nd of ...
|
AstraZeneca’s Seroquel will be sold by Alvogen Korea from 9th
‘Seroquel’ and ‘Seroquel XR Tab’ which are currently sold by AstraZeneca Korea are expected to be sold and distributed by Alvogen Korea from the coming 9th.
According to the industry concerned on the 2nd, AstraZeneca...
Pfizer’s ERP recruitment completedThe Pfizer’s Early Retirement Program(ERP) problem has been temporarily settled.
According to the industry concerned on the 2nd, Pfizer Korea finished the recruitment of ERP ca...
|
Pfizer and Novartis increasing pharmaceutical distribution costMultinational pharmaceutical companies, such as Pfizer and Novartis which have expressed opposition to the pharmaceutical distribution cost raise, started to withdraw their prev...
|
.jpg)
GSK Korea President Jin-ho Kim will resignsJin-ho Kim, President of GSK Korea, will leave the leadership position.
GSK announced President Jin-ho Kim, who has handled the North Asia region including Korea as a senior vi...
|
